ArticleCancer research2025

Targeting Innate Immune Checkpoint TREX1 Is a Safe and Effective Immunotherapeutic Strategy in Cancer.

Cong Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.